NASH Core Curriculum: A Comprehensive Online Resource Center

Download All
Gain expert insights on foundational topics in current NASH management, including pathogenesis, risk factors, diagnostic modalities, guideline-directed management, and emerging pharmacologic treatments. Watch a series of short, focused interactive videos, download slides with key data, and join the discussion around expert-authored commentaries.
Manal F. Abdelmalek, MD, MPH
Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC
Brent A. Neuschwander-Tetri, MD
Giada Sebastiani, MD
Wing-Kin Syn, MBChB, PhD, FACP, FRCP

NASH Pathogenesis

Learn about the impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease.

Brent A. Neuschwander-Tetri, MD Released: February 3, 2021

The pathogenesis of NASH is complex, but there’s insight in looking at diabetes, obesity, and insulin resistance through the lens of the liver.

Brent A. Neuschwander-Tetri, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 29, 2021 Expired: January 28, 2022

NASH Risk Factors and Prognostic Indicators

Learn about who is at risk and should be evaluated for progression to advanced fibrosis in NASH.

Manal F. Abdelmalek, MD, MPH Released: March 15, 2021

AASLD guidelines do not recommend routine screening for NAFLD or NASH, but they and other guidelines do call out patients with type 2 diabetes as warranting workup.

Manal F. Abdelmalek, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 16, 2021 Expired: March 15, 2022

Making the Diagnosis of NASH

Learn how to use noninvasive tests to identify individuals with NAFLD and determine their risk of progression to NASH fibrosis.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 27, 2021 Expired: April 26, 2022

Learn the best tools and approaches to identify NAFLD and to rule in or rule out NASH fibrosis.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Released: April 27, 2021

With the many noninvasive tests available for screening those who are at risk for NAFLD/NASH, where should we begin and what is the optimal sequence of testing? Here’s my approach.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 20, 2021 Expired: April 19, 2022

Current Management of NASH

Learn the roles of currently available approaches—and the most recent evidence—for managing NASH.

Giada Sebastiani, MD Released: June 2, 2021

There are no FDA-approved treatments for NASH. But there are still ways to manage it.

Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: June 2, 2021 Expired: June 1, 2022

Emerging Management of NASH

Hear expert insights on emerging approaches for managing NASH, targeting both hepatic and extrahepatic manifestations.

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: July 20, 2021 Expired: July 19, 2022

Hear expert perspectives on histologic and metabolic endpoints in NASH studies and how they may inform potential targets for oral, injectable, and combination NASH treatments.

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Released: July 20, 2021

My take on how emerging drugs are measuring up.

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 17, 2021 Expired: September 16, 2022

Highlights of the NASH Curriculum

Expert recap of highlights from the NASH Core Curriculum, including pathogenesis, risk factors, and current and emerging therapies for patients with NAFLD/NASH.

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: September 9, 2021 Expired: September 8, 2022

Expert recap of highlights from the NASH Core Curriculum, including pathogenesis, risk factors, and current and emerging therapies for patients with NAFLD/NASH.

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Released: September 9, 2021

Downloadable Resources for Healthcare Professionals, Patients, and Caregivers

Easy-to-read reminders on why and how to look for NAFLD and NASH in your patients.

Released: August 6, 2021

Download for your patients and their caregivers: patient-friendly overview of the impact of NASH, including its high prevalence and consequences, plus currently recommended approaches to NASH management.

Released: August 6, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue